References
- Abaza R, Keck RW, Selman SH. (2006).Intraperitoneal chemotherapy for the prevention of transitional cell carcinoma implantation. J Urol, 175, 2317–2322.
- Bao S, Thrall BD, Miller DL. (1997).Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol, 23, 953–959.
- Basude R, Wheatley MA. (2001).Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages. Ultrasonics, 39, 437–444.
- Brayman AA, Coppage ML, Vaidya S, Miller MW. (1999).Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med Biol, 25, 999–1008.
- El-Sherif DM, Wheatley MA. (2003).Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res A, 66, 347–355.
- Gao ZG, Fain HD, Rapoport N. (2005).Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release, 102, 203–222.
- Huang SL, MacDonald RC. (2004).Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta, 1665, 134–141.
- Lathia JD, Leodore L, Wheatley MA. (2004).Polymeric contrast agent with targeting potential. Ultrasonics, 42, 763–768.
- Matsumura Y, Maeda H. (1986).A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, 6387–6392.
- Miller DL, Quddus J. (2000).Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol, 26, 661–667.
- Miller DL, Dou C. (2004).Membrane damage thresholds for pulsed or continuous ultrasound in phagocytic cells loaded with contrast agent gas bodies. Ultrasound Med Biol, 30, 405–411.
- Miura S, Tachibana K, Okamoto T, Saku K. (2002).In vitro transfer of antisense oligodeoxynucleotides into coronary endothelial cells by ultrasound. Biochem Biophys Res Commun, 298, 587–590.
- Price RJ, Kaul S. (2002).Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J Cardiovasc Pharmacol Ther, 7, 171–180.
- Rapoport NY, Christensen DA, Fain HD, Barrows L, Gao Z. (2004).Ultrasound-triggered drug targeting of tumors in vitro and in vivo. Ultrasonics, 42, 943–950.
- Riveraa ES, Andradeb N, Martina G, Melitoa G, Criccoa G, Mohamada N, Davioa C, Caroa R, Bergoc RM. (1994).Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett, 86, 223–228.
- Shortencarier MJ, Dayton PA, Bloch SH, Schumann PA, Matsunaga TO, Ferrara KW. (2004).A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control, 51, 822–831.
- Suzuki R, Takizawa T, Negishi Y, Utoguchi N, Maruyama K. (2008).Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm, 354, 49–55.
- Zhao YZ, Liang HD, Mei XG, Halliwell M. (2005).Preparation, characterization and in vivo observation of phospholipid-based gas-filled microbubbles containing hirudin. Ultrasound Med Biol, 31, 1237–1243.
- Zhao YZ, Luo YK, Liang HD, Mei XG, Tang J, Lu CT, Zhang Y, Lin Q. (2006).Comparing transfection efficiency and safety for antisense oligodeoxyribonucleotide between phospholipids-based microbubbles and liposomes. J Drug Target, 14, 687–693.
- Zhao YZ, Luo YK, Lu CT, Xu JF, Tang J, Zhang M, Zhang Y, Liang HD. (2008).Phospholipids-based microbubbles sonoporation pore size and reseal of cell membrane cultured in vitro. J Drug Target, 16, 18–25.